- Home
- APLT vs AMAL Comparison
APLT vs AMAL Comparison
Compare APLT & AMAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | APLT | AMAL |
|---|---|---|
| Founded | 2016 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.0M | 958.9M |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | APLT | AMAL |
|---|---|---|
| Price | $0.11 | $33.38 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $1.25 | ★ $33.50 |
| AVG Volume (30 Days) | ★ 10.6M | 198.8K |
| Earning Date | 11-13-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 1.67% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.32 |
| Revenue | $1,000,000.00 | ★ $305,836,000.00 |
| Revenue This Year | $124.18 | $10.09 |
| Revenue Next Year | $66.67 | $8.37 |
| P/E Ratio | ★ N/A | $10.07 |
| Revenue Growth | N/A | ★ 0.56 |
| 52 Week Low | $0.09 | $25.03 |
| 52 Week High | $1.50 | $37.26 |
Technical Indicators
Market Signals| Indicator | APLT | AMAL |
|---|---|---|
| Relative Strength Index (RSI) | 28.56 | 65.24 |
| Support Level | $0.10 | $31.50 |
| Resistance Level | $0.12 | $33.62 |
| Average True Range (ATR) | 0.01 | 0.71 |
| MACD | 0.02 | -0.08 |
| Stochastic Oscillator | 37.53 | 87.98 |
Price Performance
Historical ComparisonAbout APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About AMAL Amalgamated Financial Corp. (DE)
Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers various products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management and trust and custody services.